Cargando…

MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker

BACKGROUND: Hepatocellular carcinoma (HCC) accounts for one of the most prevalent tumor types in the world. The MAP kinase-interacting kinase 1 (MNK1) functions downstream of MAP kinases such as p38 and ERK, and its potential role in cancer development is being uncovered. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xujing, Wang, Yongkun, Zhang, Qiqi, Zhuang, Huiren, Chen, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885772/ https://www.ncbi.nlm.nih.gov/pubmed/29576605 http://dx.doi.org/10.12659/MSM.909012

Ejemplares similares

Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms
por: Wang, Xujing, et al.
Publicado: (2018)

The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2020)

Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma
por: Zhang, Hong-Xia, et al.
Publicado: (2015)

Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2015)

Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas
por: Song, Zi-Bin, et al.
Publicado: (2020)

Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2020)

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
por: Fu, Binsheng, et al.
Publicado: (2017)

GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer
por: Yang, Jing, et al.
Publicado: (2016)

Expressional and functional characteristics of checkpoint kinase 1 as a prognostic biomarker in hepatocellular carcinoma
por: Bai, Encheng, et al.
Publicado: (2022)

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

A‐kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients
por: Fang, Tao, et al.
Publicado: (2020)

High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients
por: Du, Wei-Bo, et al.
Publicado: (2019)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020)

NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation
por: Lai, Xiao-Bo, et al.
Publicado: (2017)

Significant Gene Biomarker Tyrosine Kinase Non-receptor 2 Mediated Cell Proliferation and Invasion in Colon Cancer
por: Ling, Sunkai, et al.
Publicado: (2021)

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma
por: Xiao, Yong-bo, et al.
Publicado: (2018)

Protein kinase N1 promotes proliferation and invasion of liver cancer
por: Wang, Xia, et al.
Publicado: (2021)

MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer
por: Guo, Zhihua, et al.
Publicado: (2017)

Phosphorylation of the Kinase Interaction Motif in Mitogen-activated Protein (MAP) Kinase Phosphatase-4 Mediates Cross-talk between Protein Kinase A and MAP Kinase Signaling Pathways
por: Dickinson, Robin J., et al.
Publicado: (2011)

DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma
por: Wu, Hao, et al.
Publicado: (2021)

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
por: Bai, Bing, et al.
Publicado: (2019)

Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma
por: Pan, Binhua, et al.
Publicado: (2021)

MAP-ping genomic organization and organ-specific expression profiles of poplar MAP kinases and MAP kinase kinases
por: Nicole, Marie-Claude, et al.
Publicado: (2006)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer
por: Barros, Francisco Bárbara Abreu, et al.
Publicado: (2018)

SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia
por: Deng, Ailing, et al.
Publicado: (2016)

DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer
por: Hu, Shu Fang, et al.
Publicado: (2020)

Holliday junction–recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma
por: Hu, Baohong, et al.
Publicado: (2017)

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Linjun, et al.
Publicado: (2022)

AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
por: Cheng, Jidong, et al.
Publicado: (2014)

Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
por: Bai, Hansong, et al.
Publicado: (2019)

LncRNA CASC2 Regulate Cell Proliferation and Invasion by Targeting miR-155/SOCS1 Axis in Hepatocellular Carcinoma
por: Yuan, Ye, et al.
Publicado: (2023)

Differential regulation of anti-inflammatory genes by p38 MAP kinase and MAP kinase kinase 6
por: Hammaker, Deepa, et al.
Publicado: (2014)

Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome
por: Ridder, Dirk Andreas, et al.
Publicado: (2022)

MAP kinase phosphatases
por: Theodosiou, Aspasia, et al.
Publicado: (2002)

RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma
por: Li, Hong‐Shuai, et al.
Publicado: (2023)

Bidirectional Regulation of Neutrophil Migration by MAP Kinases
por: Liu, Xiaowen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ilicvtc81lfogtp7kkt3dj0lcc